Walleye Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,066
| Closed | -$3.52M | – | 4750 |
|
|
2025
Q4 | $3.44M | Buy |
+7,066
| New | +$3.29M | ﹤0.01% | 1524 |
|
|
2025
Q3 | – | Sell |
-20,884
| Closed | -$7.02M | – | 4846 |
|
|
2025
Q2 | $6M | Buy |
20,884
+11,433
| +121% | +$3.42M | 0.01% | 1107 |
|
|
2025
Q1 | $2.91M | Buy |
9,451
+9,166
| +3,216% | +$3.14M | 0.01% | 1401 |
|
|
2024
Q4 | $101K | Sell |
285
-293
| -51% | -$108K | ﹤0.01% | 3549 |
|
|
2024
Q3 | $207K | Buy |
+578
| New | +$195K | ﹤0.01% | 3042 |
|
|
2024
Q2 | – | Sell |
-1,464
| Closed | -$387K | – | 4937 |
|
|
2024
Q1 | $336K | Sell |
1,464
-15,204
| -91% | -$3.43M | ﹤0.01% | 3101 |
|
|
2023
Q4 | $3.67M | Buy |
+16,668
| New | +$3.84M | 0.01% | 1446 |
|
|
2023
Q2 | – | Sell |
-433
| Closed | -$95.9K | – | 5237 |
|
|
2023
Q1 | $97K | Sell |
433
-494
| -53% | -$122K | ﹤0.01% | 3869 |
|
|
2022
Q4 | $258K | Sell |
927
-8,588
| -90% | -$2.17M | ﹤0.01% | 3372 |
|
|
2022
Q3 | $1.99M | Buy |
9,515
+6,370
| +203% | +$1.42M | 0.01% | 1683 |
|
|
2022
Q2 | $741K | Buy |
3,145
+2,778
| +757% | +$565K | ﹤0.01% | 2514 |
|
|
2022
Q1 | $66K | Buy |
+367
| New | +$69.9K | ﹤0.01% | 4421 |
|
|
2021
Q4 | – | Sell |
-18,687
| Closed | -$3.67M | – | 5913 |
|
|
2021
Q3 | $3.45M | Buy |
18,687
+12,678
| +211% | +$2.5M | 0.01% | 1156 |
|
|
2021
Q2 | $1.08M | Sell |
6,009
-86
| -1% | -$16.4K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $1.02M | Buy |
+6,095
| New | +$1.02M | ﹤0.01% | 1896 |
|
|
2020
Q2 | – | Sell |
-1,502
| Closed | -$169K | – | 4632 |
|
|
2020
Q1 | $142K | Sell |
1,502
-1,488
| -50% | -$141K | ﹤0.01% | 2885 |
|
|
2019
Q4 | $263K | Sell |
2,990
-953
| -24% | -$83.9K | ﹤0.01% | 2945 |
|
|
2019
Q3 | $314K | Buy |
+3,943
| New | +$318K | ﹤0.01% | 2545 |
|
|
2019
Q2 | – | Sell |
-3,184
| Closed | -$298K | – | 4523 |
|
|
2019
Q1 | $374K | Buy |
3,184
+2,565
| +414% | +$299K | ﹤0.01% | 2504 |
|
|
2018
Q4 | $67K | Buy |
+619
| New | +$71.8K | ﹤0.01% | 4043 |
|
|
2017
Q2 | – | Sell |
-140
| Closed | -$19K | – | 4965 |
|
|
2017
Q1 | $19K | Sell |
140
-5,940
| -98% | -$900K | ﹤0.01% | 4148 |
|
|
2016
Q4 | $872K | Buy |
6,080
+3,728
| +159% | +$476K | 0.01% | 1629 |
|
|
2016
Q3 | $278K | Buy |
2,352
+1,542
| +190% | +$185K | ﹤0.01% | 2578 |
|
|
2016
Q2 | $86K | Buy |
+810
| New | +$90.4K | ﹤0.01% | 3622 |
|
|
2016
Q1 | – | Sell |
-301
| Closed | -$47K | – | 5864 |
|
|
2015
Q4 | $47K | Sell |
301
-699
| -70% | -$102K | ﹤0.01% | 3905 |
|
|
2015
Q3 | $131K | Buy |
1,000
+750
| +300% | +$120K | ﹤0.01% | 2717 |
|
|
2015
Q2 | $43K | Buy |
+250
| New | +$45K | ﹤0.01% | 3580 |
|
Other funds holding UTHR
ACA
JT
Walleye Trading's UTHR Position: Q1 2026 in Review
Walleye Trading sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 7,066 shares — an estimated $3.52M sold.
Walleye Trading first reported a position in UTHR in Q2 2015 and held it in 27 quarters. The position peaked at $6M in Q2 2025. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Walleye Trading reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 7,066 United Therapeutics shares in Q1 2026, an estimated $3.52M.
- Walleye Trading first reported a position in United Therapeutics in Q2 2015 and held it in 27 quarters.
- Walleye Trading's United Therapeutics position peaked at $6M in Q2 2025.
- 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.